PDRN is an injectable made from salmon or trout DNA that helps tissue rebuild and calms inflammation. Its strongest evidence is healing stubborn wounds, with fair support for easing knee arthritis pain and improving skin quality, and weaker signals elsewhere. Safety is good — mostly mild, temporary local reactions — though rigorous proof remains scarce. (Full Review)

Protocol

Skin (Aesthetic)

3–4 sessions

Dermal microinjections, 2–4 weeks apart; maintenance every few months

Joint / Tendon

3–4 weekly

Intra-articular or peritendinous injections, often ultrasound-guided

Dosing Structure

Split course

Repeated sessions rather than one large dose, sustaining the regenerative stimulus

Time to effect

Wound Healing

Weeks

Develops over the treatment course

Joint Pain

Within weeks

Relief felt within weeks; wanes after a couple of months

Skin Quality

2–3 sessions

Visible over several weeks; improves over 1–3 months as collagen remodels

Benefits

High: Accelerated healing of chronic & diabetic wounds

Medium: Knee osteoarthritis pain relief; facial skin rejuvenation

Low: Tendon & ligament pain reduction; post-surgical & acne scar improvement; hyperpigmentation & melasma reduction

Speculative: Hair growth stimulation; systemic cellular longevity effects

Contraindications

Known fish, seafood, salmon, or trout protein allergy

Active infection or inflammatory skin disease at injection site

Bleeding disorders or full-dose anticoagulation

Pregnancy and breastfeeding

Active malignancy

Key Interactions

Anticoagulants and antiplatelets (warfarin, apixaban, rivaroxaban, clopidogrel, aspirin)

NSAIDs, high-dose fish oil, and antiplatelet supplements (garlic, ginkgo, vitamin E)

Methylxanthines (caffeine, theophylline)

Additive injectables (hyaluronic acid, polynucleotides, exosomes)

Adenosine-potentiating drugs (dipyridamole)

Combined procedures (fractional CO₂ laser, microneedling, subcision, PEMF)

Risk & Side Effects

High: Injection-site reactions

Medium: Allergic & hypersensitivity reactions

Low: Nodules, granulomas & infection

Speculative: Theoretical concerns from exogenous DNA

Monitoring

Marker	Target	Why
Fasting glucose	75–90 mg/dL	Impaired glucose control slows healing
HbA1c	< 5.4%	Chronic high sugar predicts poor tissue repair
hs-CRP	< 1.0 mg/L	Gauges baseline inflammatory burden
Platelet count	150–400 × 10⁹/L	Low platelets raise bruising/bleeding risk
Ferritin	40–150 ng/mL	Iron status supports tissue repair and skin quality

Cadence: Reassess each session (every 2–4 weeks during a course), then 1–3 months after completion, and every 6–12 months during maintenance

Qualitative Assessment

Visible improvement in skin texture, fine lines, elasticity, and hydration
Reduction in joint or tendon pain and improved ease of movement
Progressive wound closure and healthier granulation tissue
Absence of persistent redness, nodules, or other local reactions between sessions
Overall satisfaction and comfort with results relative to expectations

PDRN for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment